Equillium Receives Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of EQ504
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
| EMBARQ CORPORATION (NASDAQ: EQ) | Delayed: 1.42 +0.04 (2.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.38 | 52 Week High | $49.46 | |||
| Open | $1.40 | 52 Week Low | $23.41 | |||
| Day High | $1.51 | P/E | 0.27 | |||
| Day Low | $1.39 | EPS | $5.22 | |||
| Volume | 442,540 | |||||
